Ive been very active in my 20s, running, soccer and basketball
The good news is that gastrointestinal side effects typically diminish over time as the body adapts to the medication
Biosens (Basel) 12:816 Zhou J, Battig MR, Wang Y (2010) Aptamer-based molecular recognition for biosensor development
Several meta-analyses confirm modest improvements in fasting glucose, HbA1c, and lipid profiles
Novo Nordisk's Kamogelo Mmako told Spotlight: "We have not publicly announced launch timing for Rybelsus or Wegovy in South Africa." Tirzepatide After semaglutide, tirzepatide is probably the next best known GLP-1 agonist
Sci Rep 8:5276 Striepe K, Jumar A, Ott C et al (2017) Effects of the selective sodium-glucose cotransporter 2 inhibitor empagliflozin on vascular function and central hemodynamics in patients with type 2 diabetes mellitus